https://www.prnewswire.co.uk/news-releases/dilaforette-signs-collaboration-agreement-with-arabian-gulf-university-bahrain-for-phase-2-clinical-development-of-sevuparin-for-sickle-cell-disease-568916511.html
Dilaforette Signs Collaboration Agreement With Arabian Gulf University (Bahrain) for Phase 2...
/PRNewswire/ -- Dilaforette AB, a Karolinska Development (STO:KDEV) portfolio company focused on innovative treatments for patients with sickle-cell disease,...
arabian gulf universitycollaboration agreement